Search
site map
IP Handbook Blog
Your source for expert commentary on IP management issues.
Go to the blog
About
MIHR
PIPRA
Fiocruz, Brazil
bioDevelopments- Institute
|
FREEMAN, John W
John Freeman is a Principal in the law firm of Fish & Richardson P.C., with 35 years of experience. He has a diverse practice emphasizing patent licensing and patent opinions. He specializes in biotechnology, chemistry, bioinformatics and biology. He has extensive experience in academic-industry collaborations, diligence involving intellectual property, and all aspects of patent counseling and prosecution. He also has experience in pharmaceutical patent counselling, including pre-suit investigation and strategic issues under Hatch-Waxman provisions.
Prior to joining Fish & Richardson, Mr. Freeman served in the office of general counsel at the Civil Aeronautics Board, where he was responsible for litigated cases involving administrative law. He also served as a law clerk to Justice Robert N.C. Nix of the Pennsylvania Supreme Court. He received a B.A. from Williams College in organic chemistry and a J.D. from the University of Pennsylvania Law School.
Abstract
Licensing Biotechnology Inventions
Abstract:
After providing an overview of licensing in the field of biotechnology, the chapter carefully examines the key components of a license agreement, particularly in relation to the field’s unique concerns. The chapter raises a number of issues that licensors and licensees should consider when negotiating patent license agreements. It offers precise definitions of key terms, points out areas of the agreement that merit special attention (including the relative merits of exclusive and nonexclusive licensing), considers the difficult question of how to determine a patent’s value (especially when the patent is being used for screening purposes), and gives much-needed attention to the complexities of confidentiality agreements, especially those involving academic research institutions. To make negotiations easier and more realistic, the incentives for licensors and licensees are discussed, as are some of the finer points of development collaboration. In addition, the author offers some advice about how to define patent misuse, offering some helpful suggestions about what to do should things go bad. The goal of this chapter, however, is to ensure that agreements succeed.
|